MUMBAI, India, June 20 -- Intellectual Property India has published a patent application (202517046092 A) filed by Sanegene Bio USA Inc., Woburn, U.S.A., on May 13, for 'small interfering rna targeting c3 and uses thereof.'

Inventor(s) include Zhang, Chunyang; Geng, Xin; Wang, Shiyu; and Wang, Weimin.

The application for the patent was published on June 20, under issue no. 25/2025.

According to the abstract released by the Intellectual Property India: "This disclosure relates to isolated oligonucleotides comprising duplex regions targeting human complement C3 mRNA, and delivery systems, kits and compositions comprising the same, and methods of using the same for inhibiting or downregulating C3 gene expression."

The patent application wa...